1 |
ADORA2A
| [7] Rap1 signaling pathway Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease, Alcoholism | D00045
D00045
|
Adenosine
| [3] 13 13, 58, 65 |
2 |
ADORA2A
| [7] Rap1 signaling pathway Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease, Alcoholism | D00528
D00528
|
Caffeine
| [8] 2 2, 6, 21, 46, 78, 96, 97, 265 |
3 |
ADORA2A
| [7] Rap1 signaling pathway Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease, Alcoholism | D01453
D01453
|
Caffeine
| [8] 2 2, 6, 21, 46, 78, 96, 97, 265 |
4 |
ADORA2A
| [7] Rap1 signaling pathway Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease, Alcoholism | D02769
D02769
|
Adenosine phosphate
| [1] 46 46 |
5 |
ADORA2A
| [7] Rap1 signaling pathway Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease, Alcoholism | D04641
D04641
|
Istradefylline
| [1] 6 6 |
6 |
ADORA2A
| [7] Rap1 signaling pathway Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease, Alcoholism | D05711
D05711
|
Regadenoson
| [1] 58 58 |
7 |
ADORA2A
| [7] Rap1 signaling pathway Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease, Alcoholism | D09717
D09717
|
Preladenant
| [1] 6 6 |
8 |
ADORA2A
| [7] Rap1 signaling pathway Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease, Alcoholism | D10174
D10174
|
Tozadenant
| [1] 6 6 |
9 |
ADORA2A
| [7] Rap1 signaling pathway Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease, Alcoholism | D12568
D12568
|
Regadenoson
| [1] 58 58 |